Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Dec 31, 2025
Reporting period
Not applicable
Filed with the SEC
Jan 5, 2026
CEOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references an employee stock purchase plan
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001903669-26-000002
Filed / recorded
Jan 5, 2026, 9:43 PM UTC
Added to OQRO
Oct 7, 2026, 5:52 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
SPRUCE BIOSCIENCES, INC.
Issuer CIK
1683553
Ticker
SPRB
Reporting person
Javier B. Szwarcberg
Relationship
Director, Officer
Officer title
CHIEF EXECUTIVE OFFICER
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Dec 31, 2025
Transaction code
A
Shares / units
4,690
Price per share
$4.53
Acquired / disposed
Acquired (A)
Shares owned after
19,004
Ownership form
Direct
Amendment
No
Footnotes from the filing
Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The Reporting Person acquired the maximum shares allowable pursuant to Section 423 of the Internal Revenue Code.